Clinical Trials Browser

Immunoglobulin Light-chain Amyloidosis × ixazomib × 1 year × Clear all

NCT04847453 2026-03-18

Venetoclax, MLN9708 (Ixazomib Citrate) and Dexamethasone for the Treatment of Relapsed or Refractory Light Chain Amyloidosis

Phase 1 Recruiting

Immunoglobulin Light-chain Amyloidosis

NCT03618537 2025-12-04

Ixazomib Maintenance Study in Patients With AL Amyloidosis

Phase 2 Active not recruiting

Immunoglobulin Light-chain Amyloidosis

NCT05451771 2025-07-08

Venetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) Amyloidosis

Phase 1/2 Recruiting

Immunoglobulin Light-chain Amyloidosis, Proteostasis Deficiencies